Search results
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Inherited retinal dystrophies (IRDs) are the leading cause of blindness in working-age people in the UK, and children as young as eighteen-months are regularly diagnosed.
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Join Research Development Manager, Kate Arkell as she speaks to our latest research grantees about their projects.
A new approach to treating inherited sight loss
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Despite the knock-on effects of the pandemic, there’s been a lot going on this year in the world of research! Here are snapshots of a few stories that have appeared in the Research News section of our website in 2022.
Autoimmune diseases are quite distinct from inherited retinal dystrophies.
